Stock PSL CIZZLE BIOTECHNOLOGY HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company Cizzle Biotechnology Holdings Plc

Equities

PSL

GB00BNG2VN02

Biotechnology & Medical Research

Delayed London S.E.
Other stock markets
 09:05:03 22/05/2024 pm IST 		5-day change 1st Jan Change
1.675 GBX 0.00% Intraday chart for Cizzle Biotechnology Holdings Plc 0.00% -14.10%
30/04 EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down AN
30/04 Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable plasma biomarker, a variant of CIZ1 known as CIZ1B. CIZ1 is a cell nuclear protein involved in deoxyribonucleic acid (DNA) replication, and the targeted CIZ1B variant is correlated with early-stage lung cancer. Its prototype confirmative test has been developed to address the false positive rates of computed tomography (CT) scanning. The test is intended to address a clear unmet clinical need, which is early detection of lung cancer, when curative surgical resection is possible.

Number of employees: 4

Managers

Managers TitleAgeSince
Nigel Lee DFI
 Director of Finance/CFO 63 14/21/14

Members of the board

Members of the board TitleAgeSince
Dawn Coverley BRD
 Director/Board Member 59 14/21/14
Nigel Lee DFI
 Director of Finance/CFO 63 14/21/14
John Treacy BRD
 Director/Board Member 42 29/19/29
Allan Syms CHM
 Chairman 67 21/19/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 396,391,773 237,343,096 ( 59.88 %) 0 59.88 %

Shareholders

NameEquities%Valuation
Martin Lang
10.01 %
39,661,647 10.01 % 819 410 p
Alan Miller
4.253 %
16,858,844 4.253 % 348 304 p
Unicorn Asset Management Ltd.
0.008628 %
34,200 0.008628 % 707 p
CFS Management Ltd.
0.002654 %
10,521 0.002654 % 217 p
Downing Ventures
0.001853 %
7,346 0.001853 % 152 p
Rathbones Asset Management Ltd.
0.000407 %
1,612 0.000407 % 33 p
Amati Global Investors Ltd.
0.000195 %
772 0.000195 % 16 p
FIL Gestion SASU
0.000031 %
124 0.000031 % 3 p
King & Shaxson Asset Management Ltd.
0.000007 %
26 0.000007 % 1 p

Company contact information

Cizzle Biotechnology Holdings Plc

60 Gracechurch Street 6th Floor

EC3V 0HR, London

+44 20 7469 0930

http://www.cizzlebiotechnology.com
address Cizzle Biotechnology Holdings Plc(PSL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Stock Cizzle Biotechnology Holdings Plc
-14.10% 8.45M
MODERNA, INC. Stock Moderna, Inc.
+64.23% 62.59B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.31% 41.18B
LONZA GROUP AG Stock Lonza Group AG
+44.36% 40.29B
CELLTRION, INC. Stock Celltrion, Inc.
-8.29% 27.9B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.97% 26.21B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.16% 19.09B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+7.54% 13.08B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.17% 12.05B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.72% 12.26B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PSL Stock
  4. Company Cizzle Biotechnology Holdings Plc